Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the IgG Trough Level in Subjects With Primary Immunodeficiency Switching From Standard Subcutaneous Immunoglobulin (SCIG) to Every Other Week HyQvia

NCT02881437 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02881437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02881437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the IgG Trough Level in Subjects With Primary Immunodeficiency Switching From Standard Subcutaneous Immunoglobulin (SCIG) to Every Other Week HyQvia
Lead sponsor
University Hospital, Lille
Phase
Phase 4
Overall status
Completed
Start date
November 11, 2016
Completion date
November 30, 2018
Enrollment
22 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency